Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Arizona.
Press releases published on September 19, 2025
KFSHRC akan Berpartisipasi dalam KTT C3 Davos of Healthcare™ Jepang
TOKYO, Sept. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) telah mengumumkan partisipasinya dalam KTT C3 Davos of Healthcare™ Jepang, yang berlangsung pada 24 September 2025 dengan mengangkat tema “Kolaborasi …
킹파이살 전문병원 겸 연구센터 (KFSHRC), C3 다보스 어브 헬스케어™ 일본 정상회의 참가 예정
도쿄, Sept. 20, 2025 (GLOBE NEWSWIRE) -- 사우디아라비아의 킹파이살 전문병원 겸 연구센터 (KFSHRC)가 오는 2025년 9월 24일 열리는 C3 다보스 어브 헬스케어™ 일본 정상회의 (C3 Davos of Healthcare™ Japan Summit) 에 참여한다고 밝혔다. 이번 회의는 **“삼국 협력: 국경을 넘어 가교를 구축하는 헬스케어”(A Tri-Nation Collaboration: Building Bridges …
KFSHRC akan Menyertai Sidang Kemuncak C3 Davos of Healthcare™ di Jepun
TOKYO, Sept. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) telah mengumumkan penyertaannya dalam Sidang Kemuncak C3 Davos of Healthcare™ di Jepun, yang akan berlangsung pada 24 September 2025 dengan tema “ …
KFSHRC เข้าร่วมการประชุมสุดยอดญี่ปุ่น C3 Davos of Healthcare™
โตเกียว, Sept. 20, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSHRC) ประกาศเข้าร่วมการประชุมสุดยอดญี่ปุ่น C3 Davos of Healthcare™ ซึ่งจะจัดขึ้นในวันที่ 24 กันยายน 2025 ภายใต้หัวข้อ “ความร่วมมือระดับไตรภาคี: …
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualigen …
Revive Therapeutics Announces Closing of Second Tranche of Private Placement
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company dedicated to developing innovative therapeutics for critical medical needs, …
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
SAN CARLOS, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …
Algernon Announces Preferred Share Class Approved at Annual and Special Meeting
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian healthcare company announces the voting results at its annual and special …
AHS leader honored for decades of service in Alameda County
OAKLAND, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Sambo Ly, Alameda Health System’s (AHS’) manager of interpreter services, has won the Icon Award from Bay Area news station KPIX in recognition of her decades of service to refugees and community members …
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NOVATO, Calif., Sept. 19, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …
Royalty Pharma to Present at Bernstein’s 2nd Annual Healthcare Forum
NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in a fireside chat at Bernstein’s 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET. The webcast will be …
North Oaks Unveils $50 Million, 5-Story Specialty Clinic Expansion in Hammond
HAMMOND, La., Sept. 19, 2025 (GLOBE NEWSWIRE) -- The North Oaks Health System family joined with community leaders and dignitaries today to celebrate a major milestone with a ribbon cutting for North Oaks Clinic Building 3. The five-story, 96,000-square- …
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
CARMEL, Ind., Sept. 19, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic …
PharmAla Files Amended and Restated Preliminary Base Shelf Prospectus
TORONTO, Sept. 19, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …
GENFIT Announces Discontinuation of its VS-01 Program in ACLF: VS-01 Development Refocused on UCD
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), September 19, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, …
GENFIT annonce l'arrêt de son programme VS-01 dans l'ACLF – le développement de VS-01 est recentré sur l'UCD
Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 19 septembre 2025 – GENFIT (Nasdaq et Euronext: GNFT), société biopharmaceutique engagée dans l’amélioration de la vie des patients atteints de maladies rares du foie pouvant …
Hydreight Announces Annual General Meeting Results
VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS, OTC: HYDTF, FSE: SO6) (“Hydreight” or the “Company”), is pleased to announce that at the 2025 Annual General Meeting (“AGM”) virtually held on …